Citation: Db. Allen et Nc. Fost, Ethical issues in growth hormone therapy: Where are we now? University of Wisconsin Children's Hospital-Madison, October 9-11, 1999 - Introduction, ENDOCRINOLO, 11(4), 2001, pp. 1S-2S
Citation: Al. Carrel et Db. Allen, Beyond height: Effects of growth hormone on body composition and physical function in children, ENDOCRINOLO, 11(4), 2001, pp. 30S
Citation: Db. Allen, Terminating growth-promoting growth hormone therapy: In favor of the "normal opportunity range", ENDOCRINOLO, 11(4), 2001, pp. 56S-59S
Authors:
Carrel, AL
Myers, SE
Whitman, BY
Allen, DB
Citation: Al. Carrel et al., Sustained benefits of growth hormone on body composition, fat utilization,physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent, J PED END M, 14(8), 2001, pp. 1097-1105
Authors:
Rosenfeld, R
Allen, DB
MacGillivray, MH
Alter, C
Saenger, P
Anhalt, H
Hintz, R
Katz, HP
Citation: R. Rosenfeld et al., Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders, AM J M CARE, 6(15), 2000, pp. S805-S816
Authors:
Lee, PDK
Allen, DB
Angulo, MA
Cappa, M
Carrel, AL
Castro-Magana, M
Chiumello, G
Davies, PSW
Eiholzer, U
Grugni, G
Hauffa, BP
Hintz, RL
Lammer, C
Mogul, HR
Myers, SE
Partsch, CJ
Pescovitz, OH
Ritzen, EM
Rosenfeld, RG
Sipila, I
Wilson, DM
Citation: Pdk. Lee et al., Consensus statement - Prader-Willi syndrome: Growth hormone (GH)/insulin-like growth factor axis deficiency and GH treatment, ENDOCRINOLO, 10(4), 2000, pp. 71S-73S
Authors:
Lai, HC
FitzSimmons, SC
Allen, DB
Kosorok, MR
Rosenstein, BJ
Campbell, PW
Farrell, PM
Citation: Hc. Lai et al., Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis, N ENG J MED, 342(12), 2000, pp. 851-859
Authors:
Myers, SE
Carrel, AL
Whitman, BY
Allen, DB
Citation: Se. Myers et al., Sustained benefit after 2 years of growth hormone on body composition, fatutilization, physical strength and agility, and growth in Prader-Willi syndrome, J PEDIAT, 137(1), 2000, pp. 42-49
Authors:
Carrel, AL
Huber, S
Allen, DB
Voelkerding, KV
Citation: Al. Carrel et al., Assessment of SNRPN expression as a molecular tool in the diagnosis of Prader-Willi syndrome, MOL DIAGN, 4(1), 1999, pp. 5-10
Citation: Db. Allen, Limitations of short-term studies in predicting long-term adverse effects of inhaled corticosteroids, ALLERGY, 54, 1999, pp. 29-34
Authors:
Carrel, AL
Myers, SE
Whitman, BY
Allen, DB
Citation: Al. Carrel et al., Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study, J PEDIAT, 134(2), 1999, pp. 215-221